Tag: Li Tao
Han Kun, Zhong Lun act on Sino Biopharm’s USD950m LaNova buy
Han Kun and Zhong Lun advised on Sino Biopharm’s USD950m acquisition of cancer drugmaker LaNova Medicines
Han Kun and Zhong Lun advised on Sino Biopharm’s USD950m acquisition of cancer drugmaker LaNova Medicines
Draft Advocates Amendment Bill 2026 could formalise law firms, mandate registration and admit foreign practices
91视频 senior advocate designation forces partners to leave firms, but reforms may allow continued affiliation
Follow us on LinkedIn